Consolidated Statements of Shareholders' Equity - USD ($) shares in Millions, $ in Millions | Total | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss |
Shares balance beginning of period (in shares) at Jan. 02, 2021 | | 221 | | | |
Balance at beginning of period at Jan. 02, 2021 | $ 3,530 | $ 2 | $ 2,901 | $ 661 | $ (34) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Share-based compensation expense | 10 | | 10 | | |
Proceeds from employee stock purchase plan | 5 | | 5 | | |
Vested restricted stock units, net (in shares) | | 1 | | | |
Vested restricted stock units, net | 0 | | 0 | | |
Exercise of stock options (in shares) | | 0 | | | |
Exercise of stock options | 4 | | 4 | | |
Tax withholding payments for net share-settled equity awards | (12) | | (12) | | |
Series A convertible preferred stock dividends | (15) | | | (15) | |
Unrecognized gain (loss) on interest rate swaps, net of income tax | 2 | | | | 2 |
Net income | (24) | | | (24) | |
Shares balance end of period (in shares) at Apr. 03, 2021 | | 222 | | | |
Balance at end of period at Apr. 03, 2021 | 3,500 | $ 2 | 2,908 | 622 | (32) |
Shares balance beginning of period (in shares) at Jan. 02, 2021 | | 221 | | | |
Balance at beginning of period at Jan. 02, 2021 | 3,530 | $ 2 | 2,901 | 661 | (34) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 95 | | | | |
Shares balance end of period (in shares) at Oct. 02, 2021 | | 223 | | | |
Balance at end of period at Oct. 02, 2021 | 3,648 | $ 2 | 2,952 | 723 | (29) |
Shares balance beginning of period (in shares) at Apr. 03, 2021 | | 222 | | | |
Balance at beginning of period at Apr. 03, 2021 | 3,500 | $ 2 | 2,908 | 622 | (32) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Share-based compensation expense | 13 | | 13 | | |
Proceeds from employee stock purchase plan | 5 | | 5 | | |
Exercise of stock options | 8 | | 8 | | |
Tax withholding payments for net share-settled equity awards | (1) | | (1) | | |
Series A convertible preferred stock dividends | (9) | | | (9) | |
Unrecognized gain (loss) on interest rate swaps, net of income tax | 2 | | | | 2 |
Net income | 55 | | | 55 | |
Shares balance end of period (in shares) at Jul. 03, 2021 | | 222 | | | |
Balance at end of period at Jul. 03, 2021 | 3,573 | $ 2 | 2,933 | 668 | (30) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Share-based compensation expense | 13 | | 13 | | |
Proceeds from employee stock purchase plan | 6 | $ 1 | 6 | | |
Exercise of stock options | 1 | | 1 | | |
Series A convertible preferred stock dividends | (9) | | | (9) | |
Unrecognized gain (loss) on interest rate swaps, net of income tax | 1 | | | | 1 |
Net income | 64 | | | 64 | |
Shares balance end of period (in shares) at Oct. 02, 2021 | | 223 | | | |
Balance at end of period at Oct. 02, 2021 | 3,648 | $ 2 | 2,952 | 723 | (29) |
Shares balance beginning of period (in shares) at Jan. 01, 2022 | | 223 | | | |
Balance at beginning of period at Jan. 01, 2022 | 3,735 | $ 2 | 2,970 | 782 | (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Share-based compensation expense | 12 | | 12 | | |
Proceeds from employee stock purchase plan | 5 | | 5 | | |
Vested restricted stock units, net (in shares) | | 1 | | | |
Vested restricted stock units, net | 0 | | 0 | | |
Exercise of stock options (in shares) | | 0 | | | |
Exercise of stock options | 2 | | 2 | | |
Tax withholding payments for net share-settled equity awards | (16) | | (16) | | |
Series A convertible preferred stock dividends | (9) | | | (9) | |
Net income | (7) | | | (7) | |
Shares balance end of period (in shares) at Apr. 02, 2022 | | 224 | | | |
Balance at end of period at Apr. 02, 2022 | 3,722 | $ 2 | 2,973 | 766 | (19) |
Shares balance beginning of period (in shares) at Jan. 01, 2022 | | 223 | | | |
Balance at beginning of period at Jan. 01, 2022 | 3,735 | $ 2 | 2,970 | 782 | (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 172 | | | | |
Shares balance end of period (in shares) at Oct. 01, 2022 | | 225 | | | |
Balance at end of period at Oct. 01, 2022 | 3,927 | $ 2 | 3,017 | 927 | (19) |
Shares balance beginning of period (in shares) at Apr. 02, 2022 | | 224 | | | |
Balance at beginning of period at Apr. 02, 2022 | 3,722 | $ 2 | 2,973 | 766 | (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Share-based compensation expense | 9 | | 9 | | |
Proceeds from employee stock purchase plan | 7 | | 7 | | |
Exercise of stock options | 5 | | 5 | | |
Series A convertible preferred stock dividends | (9) | | | (9) | |
Net income | 70 | | | 70 | |
Shares balance end of period (in shares) at Jul. 02, 2022 | | 224 | | | |
Balance at end of period at Jul. 02, 2022 | 3,804 | $ 2 | 2,994 | 827 | (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 109 | | | | |
Shares balance end of period (in shares) at Oct. 01, 2022 | | 225 | | | |
Balance at end of period at Oct. 01, 2022 | $ 3,927 | $ 2 | $ 3,017 | $ 927 | $ (19) |